MRNA Synthesis & Manufacturing Market by Services (Capping & Tailing, Formulation, in Silico Design), Service Type (Custom MRNA Synthesis, Standard MRNA Production), Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-user - Global Forecast 2025-2030- Product Image

Sale

MRNA Synthesis & Manufacturing Market by Services (Capping & Tailing, Formulation, in Silico Design), Service Type (Custom MRNA Synthesis, Standard MRNA Production), Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-user - Global Forecast 2025-2030

Report
199 Pages
November 2024
Region: Global
360iResearch™
ID: 6021445

UP TO €679EUR$697USD£566GBP OFF until Dec 31^st 2024

The mRNA Synthesis & Manufacturing Market grew from USD 2.48 billion in 2023 to USD 2.71 billion in 2024. It is expected to continue growing at a CAGR of 9.35%, reaching USD 4.65 billion by 2030.

The mRNA synthesis and manufacturing market is a burgeoning segment within biotechnology that focuses on the production and development of messenger RNA (mRNA) used in various therapeutic and research applications. The necessity of mRNA technology primarily stems from its pivotal role in developing vaccines, especially highlighted by the rapid development of COVID-19 vaccines. Beyond vaccines, mRNA is increasingly essential in gene therapy, cancer treatment, and protein replacement therapies. The end-use scope predominantly includes pharmaceutical and biotechnology companies, research institutions, and healthcare providers.

Key factors influencing market growth include advancements in mRNA technology, rising investment in research and development, and the increasing prevalence of infectious diseases and cancer. There are substantial opportunities in developing a diverse range of therapeutic applications of mRNA, expanding beyond vaccines to include personalized medicine and rare disease treatments. Companies can capture these opportunities by investing in research to enhance mRNA stability and delivery mechanisms, which are current market limitations. Market growth also faces challenges such as high production costs, storage and distribution complexities, stringent regulatory frameworks, and competition from traditional therapies.

Addressing these challenges requires innovation in scalable manufacturing processes and improved delivery systems to stabilize and effectively transport mRNA to target cells. The best areas for innovation include developing novel lipid nanoparticles or other delivery vehicles to enhance cellular uptake and off-target effects and researching methods to lower production costs. Insight into the market nature suggests it is highly dynamic and competitive, with rapid developments.

To capitalize on this, companies should engage in strategic partnerships and collaborations to leverage cross-industry expertise and facilitate regulatory navigation. Simultaneously, keeping abreast of technological advancements and focusing on pipeline diversification will be vital for sustained growth in the mRNA synthesis and manufacturing market.

Understanding Market Dynamics in the mRNA Synthesis & Manufacturing Market

The mRNA Synthesis & Manufacturing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing incidence of infectious diseases across the globe
- Partnerships between biotech firms and educational institutions
Market Restraints
- Complex and costly manufacturing processes associated with mRNA
Market Opportunities
- Emerging mRNA applications in cancer therapeutics
- Integrating data analytics and AI to enhance mRNA sequence design and optimization
- Significant funding and investment from governments and private entities
Market Challenges
- Ethical concerns associated with mRNA synthesis & manufacturing
- Diificulties in navigating the complex regulatory landscape for mRNA

Exploring Porter’s Five Forces for the mRNA Synthesis & Manufacturing Market

Porter’s Five Forces framework further strengthens the insights of the mRNA Synthesis & Manufacturing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the mRNA Synthesis & Manufacturing Market

External macro-environmental factors deeply influence the performance of the mRNA Synthesis & Manufacturing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the mRNA Synthesis & Manufacturing Market

The mRNA Synthesis & Manufacturing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the mRNA Synthesis & Manufacturing Market

The mRNA Synthesis & Manufacturing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the mRNA Synthesis & Manufacturing Market

The mRNA Synthesis & Manufacturing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the mRNA Synthesis & Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Aurigene Pharmaceutical Services Ltd. by Dr. Reddy's Laboratories Limited, Bio-Synthesis Inc., Creative Biogene, Creative Biolabs, Croyez Bioscience Co., Ltd., Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Genewiz by Azenta Life Sciences, GenScript Biotech Corporation, Jena Bioscience GmbH by Enzo Biochem Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs, Inc., PackGene Biotech, Inc., Promega Corporation, Samsung Biologics Co., Ltd., Sartorius AG, ST Pharm, System Biosciences, LLC, Takara Bio Inc., Telesis Bio Inc., Thermo Fisher Scientific Inc., TriLink BioTechnologies LLC by Maravai Intermediate Holdings, LLC, and WuXi Biologics (Cayman) Inc.

Market Segmentation & Coverage

This research report categorizes the mRNA Synthesis & Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
- Capping & Tailing
- Formulation
- In Silico Design
- Modification & Optimization
- Purification & Quality Control
- Storage & Distribution
- Template DNA Preparation
Service Type
- Custom mRNA Synthesis
  - Client-Specific mRNA Orders
  - Tailored Research Specifications
- Standard mRNA Production
  - Cataloged mRNA Variants
  - Off-the-Shelf mRNA Selections
Manufacturing Process
- Advanced LNP Formulation Technology
- Enzymatic Capping & Cap Analogues
- Genetic Engineering & Codon Optimization
- In Vitro Transcription
- Plasmid DNA Template
- Polyadenylation
- RNA Purification Techniques
Manufacturing Scale
- Commercial Scale
- Lab Scale
- Pilot Scale
Technology
- In Vitro Synthesis
- In Vivo Synthesis
Application
- Therapeutics
  - Cancer
  - Infectious Diseases
  - Rare Diseases
- Vaccines
  - Prophylactic Vaccines
  - Therapeutic Vaccines
Usage
- Human Use
- Veterinary Use
End-User
- Academic & Research Institutes
  - Government Research Bodies
  - University Laboratories
- Contract Manufacturing Organizations
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of infectious diseases across the globe
5.1.1.2. Partnerships between biotech firms and educational institutions
5.1.2. Restraints
5.1.2.1. Complex and costly manufacturing processes associated with mRNA
5.1.3. Opportunities
5.1.3.1. Emerging mRNA applications in cancer therapeutics
5.1.3.2. Integrating data analytics and AI to enhance mRNA sequence design and optimization
5.1.3.3. Significant funding and investment from governments and private entities
5.1.4. Challenges
5.1.4.1. Ethical concerns associated with mRNA synthesis & manufacturing
5.1.4.2. Diificulties in navigating the complex regulatory landscape for mRNA
5.2. Market Segmentation Analysis
5.2.1. Services: Increasing usage of the modification & optimization services focuses on enhancing stability and translational efficiency
5.2.2. Service Type: Significant custom mRNA synthesis utilization in delivering personalized solutions, attracting biotech startups and research institutions
5.2.3. Manufacturing Process: Substantial adoption of genetic engineering & codon optimization process for maximizing protein yield and ensuring optimal gene expression
5.2.4. Manufacturing Scale: Increased commercial scale production driven by growing pharmaceutical companies and established biotech firms
5.2.5. Technology: Rising adoption of in vitro synthesis due to its rapid production cycle and the control level offered over the synthesis process
5.2.6. Application: Expanding role of mRNA synthesis and manufacturing for the vaccines
5.2.7. Usage: Evolving need for mRNA-based therapeutics and vaccines for humans usage
5.2.8. End-User: Pharmaceutical & biotechnology companies are heavily invested in mRNA technology for its potential in vaccine and therapeutic development
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. mRNA Synthesis & Manufacturing Market, by Services

6.1. Introduction
6.2. Capping & Tailing
6.3. Formulation
6.4. In Silico Design
6.5. Modification & Optimization
6.6. Purification & Quality Control
6.7. Storage & Distribution
6.8. Template DNA Preparation

7. mRNA Synthesis & Manufacturing Market, by Service Type

7.1. Introduction
7.2. Custom mRNA Synthesis
7.2.1. Client-Specific mRNA Orders
7.2.2. Tailored Research Specifications
7.3. Standard mRNA Production
7.3.1. Cataloged mRNA Variants
7.3.2. Off-the-Shelf mRNA Selections

8. mRNA Synthesis & Manufacturing Market, by Manufacturing Process

8.1. Introduction
8.2. Advanced LNP Formulation Technology
8.3. Enzymatic Capping & Cap Analogues
8.4. Genetic Engineering & Codon Optimization
8.5. In Vitro Transcription
8.6. Plasmid DNA Template
8.7. Polyadenylation
8.8. RNA Purification Techniques

9. mRNA Synthesis & Manufacturing Market, by Manufacturing Scale

9.1. Introduction
9.2. Commercial Scale
9.3. Lab Scale
9.4. Pilot Scale

10. mRNA Synthesis & Manufacturing Market, by Technology

10.1. Introduction
10.2. In Vitro Synthesis
10.3. In Vivo Synthesis

11. mRNA Synthesis & Manufacturing Market, by Application

11.1. Introduction
11.2. Therapeutics
11.2.1. Cancer
11.2.2. Infectious Diseases
11.2.3. Rare Diseases
11.3. Vaccines
11.3.1. Prophylactic Vaccines
11.3.2. Therapeutic Vaccines

12. mRNA Synthesis & Manufacturing Market, by Usage

12.1. Introduction
12.2. Human Use
12.3. Veterinary Use

13. mRNA Synthesis & Manufacturing Market, by End-User

13.1. Introduction
13.2. Academic & Research Institutes
13.2.1. Government Research Bodies
13.2.2. University Laboratories
13.3. Contract Manufacturing Organizations
13.4. Pharmaceutical & Biotechnology Companies

14. Americas mRNA Synthesis & Manufacturing Market

14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States

15. Asia-Pacific mRNA Synthesis & Manufacturing Market

15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam

16. Europe, Middle East & Africa mRNA Synthesis & Manufacturing Market

16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom

17. Competitive Landscape

17.1. Market Share Analysis, 2023
17.2. FPNV Positioning Matrix, 2023
17.3. Competitive Scenario Analysis
17.3.1. TriLink and Alphazyme's CleanScribe RNA Polymerase revolutionizes mRNA synthesis with reduced dsRNA formation
17.3.2. Partnership between Telesis Bio and Beckman Coulter Life Sciences transforms DNA and mRNA synthesis through scalable and high-fidelity biofoundries
17.3.3. Strategic partnership in mRNA synthesis, Primrose Bio, and ExPLoRNA transform therapeutic advancements through innovation
17.3.4. Strategic acquisition of echelon biosciences by VION biosciences to increase mRNA therapies and life science offerings
17.3.5. GSK collaborates with Touchlight to revolutionize mRNA vaccine production using advanced dbDNA technology
17.3.6. Applied DNA secures patent for innovative Linea IVT technology advancing mRNA synthesis efficiency
17.3.7. WACKER unveils mRNA competence center in Germany to expand global pandemic preparedness and biotech innovation
17.3.8. Takara Bio launched genetically enhanced PrimeCap T7 RNA polymerase, revolutionizing safe mRNA synthesis for advanced therapeutics
17.3.9. TriLink BioTechnologies Expands Late-Phase mRNA Drug Manufacturing with New San Diego Facility
17.3.10. Strategic alliance between PackGene Biotech and Kudo Biotechnology transforms global mRNA manufacturing landscape with comprehensive end-to-end solutions
17.4. Strategy Analysis & Recommendation
17.4.1. GenScript Biotech Corporation
17.4.2. Thermo Fisher Scientific Inc.
17.4.3. Samsung Biologics Co., Ltd.
17.4.4. Danaher Corporation

List of Figures

FIGURE 1. MRNA SYNTHESIS & MANUFACTURING MARKET MULTI-CURRENCY
FIGURE 2. MRNA SYNTHESIS & MANUFACTURING MARKET MULTI-LANGUAGE
FIGURE 3. MRNA SYNTHESIS & MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 4. MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 17. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 19. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
FIGURE 21. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 23. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 27. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 29. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 32. MRNA SYNTHESIS & MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 33. MRNA SYNTHESIS & MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. MRNA SYNTHESIS & MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MRNA SYNTHESIS & MANUFACTURING MARKET DYNAMICS
TABLE 7. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CAPPING & TAILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY IN SILICO DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MODIFICATION & OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY PURIFICATION & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STORAGE & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TEMPLATE DNA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CLIENT-SPECIFIC MRNA ORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TAILORED RESEARCH SPECIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CATALOGED MRNA VARIANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY OFF-THE-SHELF MRNA SELECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ADVANCED LNP FORMULATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ENZYMATIC CAPPING & CAP ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY GENETIC ENGINEERING & CODON OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY PLASMID DNA TEMPLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY POLYADENYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY RNA PURIFICATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY LAB SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY IN VITRO SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY IN VIVO SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VETERINARY USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY GOVERNMENT RESEARCH BODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 99. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 101. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 102. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 103. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 104. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 105. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 108. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 109. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 110. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. CANADA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 112. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 122. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. MEXICO MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 166. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 168. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 169. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 170. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 171. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 172. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 175. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 176. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 177. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. CHINA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 179. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 180. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 181. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 182. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 183. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 184. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 185. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 188. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 189. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 190. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. INDIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 205. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 207. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 208. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 209. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 210. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 211. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 214. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 215. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 216. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. JAPAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 283. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 284. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 292. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 293. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 294. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. THAILAND MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY CUSTOM MRNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY STANDARD MRNA PRODUCTION, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM MRNA SYNTHESIS & MANUFACTURING MARKET

Companies Mentioned

Aurigene Pharmaceutical Services Ltd. by Dr. Reddy's Laboratories Limited
Bio-Synthesis Inc.
Creative Biogene
Creative Biolabs
Croyez Bioscience Co., Ltd.
Danaher Corporation
FUJIFILM Wako Pure Chemical Corporation
Genewiz by Azenta Life Sciences
GenScript Biotech Corporation
Jena Bioscience GmbH by Enzo Biochem Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
PackGene Biotech, Inc.
Promega Corporation
Samsung Biologics Co., Ltd.
Sartorius AG
ST Pharm
System Biosciences, LLC
Takara Bio Inc.
Telesis Bio Inc.
Thermo Fisher Scientific Inc.
TriLink BioTechnologies LLC by Maravai Intermediate Holdings, LLC
WuXi Biologics (Cayman) Inc

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	November 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.71 billion
Forecasted Market Value ( USD ) by 2030	$ 4.65 billion
Compound Annual Growth Rate	9.3%
Regions Covered	Global
No. of Companies Mentioned	24

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3455EUR$3,545USD£2,879GBP €3839EUR$3,939USD£3,199GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6113EUR$6,272USD£5,093GBP €6793EUR$6,969USD£5,659GBP

Understanding Market Dynamics in the mRNA Synthesis & Manufacturing Market

Exploring Porter’s Five Forces for the mRNA Synthesis & Manufacturing Market

Applying PESTLE Analysis to the mRNA Synthesis & Manufacturing Market

Analyzing Market Share in the mRNA Synthesis & Manufacturing Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the mRNA Synthesis & Manufacturing Market

Strategic Recommendations for Success in the mRNA Synthesis & Manufacturing Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report by Type (Capping Agents, Nucleotides), Application (Vaccine Production, Therapeutics Production), End-use, Region, and Segment Forecasts, 2024-2030

U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report, Type (Capping Agents, Nucleotides, Plasmid DNA), Application (Vaccine, Therapeutics), End-use, and Segment Forecasts, 2024-2030

mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029

mRNA Synthesis and Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area, Therapeutic Area and Key Geographical Regions

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024